Andrew Bergman (New York) joined KKR in 2014 and is a member of the Health Care industry team within the firm's Americas Private Equity platform. He currently serves as a Board Director or Observer for BridgeBio Pharma, Covenant Physician Partners, Geode Health and PetVet Care Centers. He was previously involved with KKR's investments in Ajax Health, Arbor Pharmaceuticals, Eidos Therapeutics, EPIX Therapeutics, Hanger, Lake Region Medical, Spirox, and SunFire. Mr. Bergman holds a B.A., with honors, in Economics-Accounting and Psychology and a M.A. in Finance from Claremont McKenna College.